Fig. 2From: Targeting macrophages in hematological malignancies: recent advances and future directionsHistory of discovering phagocytosis-associated checkpoint inhibitors: over the past two decades, a great deal of progress has been made in identifying phagocytosis-associated checkpointsBack to article page